Skip to main navigation Skip to search Skip to main content

Human endogenous retrovirus (HERV) expression is not induced by treatment with the histone deacetylase (HDAC) inhibitors in cellular models of HIV-1 latency

  • Tara Hurst
  • , Matthew Pace
  • , Aris Katzourakis
  • , Rodney Phillips
  • , Paul Klenerman
  • , John Frater*
  • , Gkikas Magiorkinis
  • *Corresponding author for this work
    • University of Oxford
    • John Radcliffe Hospital
    • University of New South Wales

    Research output: Contribution to journalArticlepeer-review

    28 Citations (SciVal)
    Original languageEnglish
    Article number10
    JournalRetrovirology
    Volume13
    Issue number1
    DOIs
    Publication statusPublished (VoR) - 6 Feb 2016

    Funding

    TH and GM are supported by an MRC Clinician Scientist Fellowship awarded to GM. AK is supported by a Royal Society University Research Fellowship. JF is supported by a MRC Senior Clinical Fellowship, the Oxford Martin School and the Oxford NIHR Comprehensive Biomedical Research Centre.

    Keywords

    • Endogenous retroviruses
    • HDAC inhibitors
    • HERV-K (HML-2)
    • HIV-1 cure
    • HIV-1 latency

    Fingerprint

    Dive into the research topics of 'Human endogenous retrovirus (HERV) expression is not induced by treatment with the histone deacetylase (HDAC) inhibitors in cellular models of HIV-1 latency'. Together they form a unique fingerprint.

    Cite this